From the Tahmidids to hold two important national tests until the beginning of diabetes

According to RCO News Agency, The field of science and universities of Iran and the world today witnessed a variety of news on Thursday, February 23, in which we will present a summary of the most important of these events.

Dear ISNA News Agency, you can access the content of your desired news by clicking on any of the blue headlines.

*Applicants in the PhD exam

Ph.D’s Ph.D. (PH.D) PhD exam will be held on Thursday, March 23, based on the information contained on the card in these tests. The card will be posted on the Information Portal of the State Education Assessment Organization on Monday, February 23.

Candidates who have been applying for a quota for the registration stage of the Ph.D. (PH.D) in the PH.D (semi -focused) entrance exam, but their quota has not been approved by the relevant organ for any reason until March 9th. Do.

*Clinical testing on nanodarsia for type 2 diabetes begins

The US Food and Drug Administration (FDA) has authorized the beginnings of clinical tests a new nanoparticle -based treatment method to deal with type 2 diabetes.

Developed by CorMaceuticals Corremaceuticals, this treatment has raised hopes for stopping the disease and even restoring the function of pancreatic beta cells. Type 2 diabetes, which affects about 5 million Americans, is due to the immune system attack on insulin -producing beta cells.

*Registration requirements in the field of non -examination disciplines.

Shahed University announced that according to the unauthorized admission of talents among students and graduates of the university based on the Talent Regulations of the Ministry of Science, Research and Technology, and in accordance with the highly taught and talented undergraduate courses of Shahed University and Shahed University. Other universities, after reviewing scientific and research documents, conducting interviews and general public competence for the daily course of the student graduate student of the academic year 1-5.

*Key Vice President’s Scientific Approval to Support for Scholars

During Hussein Afshin’s recent visit to Ilam province, five important resolutions were approved that could transform the technology infrastructure and development of knowledge -based companies in the province.

*Innovation of an innovative way to simulate brain tumor in the laboratory

Scientists have devised an innovative way of developing patient brain tumors in the laboratory, which simulates the main structure and molecular characteristics of the patient’s tumor as much as possible.

*Sam Altman specified the Openai Road Map

Sam Openai CEO Sam Altman announced on the X platform that the company’s next product is the GPT-2.5, known as Orion and will be the last model that cannot be deeply thought and reasonable. ️

*British universities concern about fraud and fraud with Deep Fake

British universities, who are looking to save time and money by automating their interviews with international students, have a new threat: applicants who use Deep Fake.

*Launch the first “Comprehensive Student Health Comprehensive” Center

Deputy Director of Cultural and Student of Tehran University of Medical Sciences, referring to the launch of the first comprehensive student health center at the university, said: “By exploiting this center we can provide 5,500 Iranian and international health services.”

The end of the message